Identification of Novel Drug Candidates for the Inhibition of Catalytic Cleavage Activity of Coronavirus 3CL-like Protease Enzyme

MLA

Khalid Mashay Al-Anazi, et al. “Identification of Novel Drug Candidates for the Inhibition of Catalytic Cleavage Activity of Coronavirus 3CL-like Protease Enzyme.” Current Pharmaceutical Biotechnology, vol. 23, June 2022, pp. 959–69. EBSCOhost, https://doi.org/10.2174/1389201022666210604150041.

APA

Khalid Mashay Al-Anazi, Mohammad Abul Farah, Mohammad Ajmal Ali, Joongku Lee, & Arun Bahadur Gurung. (2022). Identification of Novel Drug Candidates for the Inhibition of Catalytic Cleavage Activity of Coronavirus 3CL-like Protease Enzyme. Current Pharmaceutical Biotechnology, 23, 959–969. https://doi.org/10.2174/1389201022666210604150041

Chicago

Khalid Mashay Al-Anazi, Mohammad Abul Farah, Mohammad Ajmal Ali, Joongku Lee, and Arun Bahadur Gurung. 2022. “Identification of Novel Drug Candidates for the Inhibition of Catalytic Cleavage Activity of Coronavirus 3CL-like Protease Enzyme.” Current Pharmaceutical Biotechnology 23 (June): 959–69. doi:10.2174/1389201022666210604150041.